The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology

Overview

Elevate Your Hematology CME

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology online CME program brings together a distinguished group of experts to present current diagnostic and therapeutic strategies. Enhance patient care and prep for your board exam with topics like molecular genetics, leukemia, bone marrow failures, transfusion medicine, and more. It’s continuing medical education that will help you to better:

• Apply current/recommended hematology guidelines in clinical practice
• Perform differential diagnosis of complex hematologic disorders
• Identify and apply current therapeutic options for hematologic disorders
• Evaluate and interpret up-to-date literature relevant to clinical practice in hematology
• Illustrate knowledge of pathophysiology of hematology disorders
• Apply knowledge gained to the ABIM certification/recertification

This program is also available as part of the combined Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology CME course found here.

Topics / Speakers

Molecular Genetics of Cancer - Nikhil Wagle, MD

Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents - Geoffrey I. Shapiro, MD, PhD

Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment - Geoffrey I. Shapiro, MD, PhD

Infections in Cancer Patients - Lindsey Baden, MD

Symptom Management in Patients with Cancer - Andrew J. Lawton, MD

Communication: The Key to Excellence in End-of-Life Care - Rachelle E. Bernacki, MD, MS, FAAHPM, AGSF

Biology of Hematopoietic Stem Cell Transplantation - Robert J. Soiffer, MD

Biology of Acute Leukemia and Myelodysplastic Syndromes - Benjamin L. Ebert, MD, PhD

Acute Leukemias - Daniel J. DeAngelo, MD, PhD

Myelodysplastic Syndrome - Eric S. Winer, MD

Chronic Myelogenous Leukemia - Marlise R. Luskin, MD

Myeloproliferative Syndromes - Ann M. Mullally, MD

Multiple Myeloma - Kenneth C. Anderson, MD

Waldenstrom Macroglobulemia and Amyloidosis - Jorge J. Castillo, MD

Low Grade Lymphomas - Caron A. Jacobson, MD

Aggressive Non-Hodgkin Lymphoma - Eric D. Jacobsen, MD

Hodgkin's Lymphoma - Reid W. Merryman, MD

Diagnosis and Treatment of CLL and Related B Cell Malignancies - Matthew S. Davids, MD

Hematopoiesis and Cytokines - David T. Scadden, MD

Acquired Bone Marrow Failure - Julie-Aurore Losman, MD, PhD

Congenital Bone Marrow Failure - Akiko Shimamura, MD, PhD

Hemophagocytic Syndromes and Related Immunodeficiencies - Barbara A. Degar, MD

Anemia – An Overview - Robert Stern, MD

Iron Deficiency and Iron Overload - Mark D. Fleming, MD, PhD

Immune Hemolytic Anemia - Richard M. Kaufman, MD

Non-immune Hemolytic Anemia - David E. Golan, PhD, MD

Sickle Cell Disease - Maureen M. Achebe, MD, MPH

Thalassemia and Other Hemoglobinopathies - Matthew M. Heeney, MD

Disorders of Neutrophils - Nancy Berliner, MD

Acquired Thrombocytopenias - Elisabeth M. Battinelli, MD, PhD

Hemophilia - Aric D. Parnes, MD

Von Willebrand Disease and Congenital Platelet Disorders - Nathan T. Connell, MD, MPH

Congenital and Acquired Thrombophilia - Kenneth A. Bauer, MD

Use of Direct Oral Anticoagulants in Clinical Practice - Jean M. Connors, MD

Transfusion Medicine for the Clinician - Walter H. Dzik, MD

Faculty

Accreditation / Pass Guarantee

Accreditation

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing designates this enduring material for a maximum of 24 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 24 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Date of Original Release: July 15, 2022
Termination Date: July 15, 2025

Learning Objectives

At the conclusion of this activity, the participant will be able to:

• Apply current/recommended hematology guidelines in clinical practice
• Perform differential diagnosis of complex clinical presentations related to hematologic disorders
• Identify/apply current therapeutic options for specific hematologic disorders
• Review and interpret up-to-date literature relevant to clinical practice in hematology
• Demonstrate knowledge of pathophysiology as it applies to management of hematology disorders
• Apply knowledge gained to the ABIM certification/recertification hematology and oncology examinations

Intended Audience

The activity was planned for fellows/trainees, practicing hematology specialists (MDs), and other professional affiliates (internists with an interest in hematology) who are preparing to take ABIM board review or recertification examinations, or who seek CME activities to improve patient care in the area of hematology.

Board Pass Guarantee

We Guarantee You'll Pass! Diligent course study and successful completion of the CME quiz provides the strongest likelihood of passing board certification or maintenance of certification exams. Oakstone is so confident of your success that we guarantee it. If you do not pass your exam on the first attempt, mail us a copy of your board failure notification, plus our system certificate reflecting your successful completion of the CME quizzes for the board review product purchased. You will receive a credit for the purchase price paid (less any discounts or premium), which you may apply to future purchases with Oakstone. Your exam record will be destroyed. Your board failure notification can be mailed to: Oakstone, P.O. Box 190165, Birmingham, AL 35219. If you have any questions on this policy, please feel free to contact Customer Service at 1-800-633-4743.

Quick Facts

Providers: Brigham and Women's Hospital and
Dana-Farber Cancer Institute

Course Directors:

Maureen M. Achebe, MD, MPH

Assistant Professor of Medicine

Harvard Medical School

Division of Hematology

Department of Medicine

Brigham and Women's Hospital

Nancy Berliner, MD

Professor of Medicine

Harvard Medical School

Chief, Division of Hematology

Department of Medicine

Brigham and Women's Hospital

Course Director, The Brigham Board Review Distance Learning Series:

Ajay K. Singh, MBBS, FRCP (UK), MBA

Department of Medicine

Brigham and Women's Hospital

Credits: Earn up to 24 AMA PRA Category 1 Credits™ and 24 ABIM MOC points